CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tetrahydrofolic acid
Accession: CHEBI:26907
browse the term
Definition: A group of heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with one or more L-glutamic acid units.
Synonyms: related_synonym: tetrahydrofolate; tetrahydrofolates; tetrahydrofolic acids
cyclic_relationship: is_conjugate_acid_of CHEBI:67016
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
increases metabolic processing
ISO
ALDH1L2 protein results in increased metabolism of 10-formyltetrahydropteroylglutamic acid
CTD
PMID:21238436
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
G
Mthfr
methylenetetrahydrofolate reductase
increases metabolic processing increases reduction
ISO
MTHFR protein results in increased metabolism of 5,10-methylenetetrahydrofolic acid MTHFR protein results in increased reduction of 5,10-methylenetetrahydrofolic acid
CTD
PMID:7647779 PMID:16187112
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
increases chemical synthesis
ISO
ALDH1L2 protein results in increased chemical synthesis of 5,6,7,8-tetrahydrofolic acid
CTD
PMID:21238436
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
G
Alpi
alkaline phosphatase, intestinal
multiple interactions
ISO
5,6,7,8-tetrahydrofolic acid inhibits the reaction [Methotrexate results in increased activity of ALPI protein]
CTD
PMID:16598758
NCBI chr 9:94,197,616...94,201,910
Ensembl chr 9:94,197,618...94,201,084
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
5,6,7,8-tetrahydrofolic acid results in decreased expression of IGF1R mRNA
CTD
PMID:16728583
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions
ISO
5,6,7,8-tetrahydrofolic acid inhibits the reaction [Methotrexate results in decreased expression of MTR protein]; [Thymidine co-treated with Hypoxanthine co-treated with 5,6,7,8-tetrahydrofolic acid] inhibits the reaction [Methotrexate results in decreased expression of MTR protein]
CTD
PMID:16598758
NCBI chr17:66,210,444...66,295,014
Ensembl chr17:66,210,461...66,295,014
G
Slc19a1
solute carrier family 19 member 1
multiple interactions decreases activity
EXP
5,6,7,8-tetrahydrofolic acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] 5,6,7,8-tetrahydrofolic acid results in decreased activity of SLC19A1 protein
CTD
PMID:14612385
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
G
Tyms
thymidylate synthetase
increases activity
EXP
5,6,7,8-tetrahydrofolic acid results in increased activity of TYMS protein
CTD
PMID:187325
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
Leucovorin inhibits the reaction [Methotrexate results in decreased expression of ABCC2 protein]
CTD
PMID:16925582
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
G
Alb
albumin
multiple interactions
ISO
[Leucovorin co-treated with Cisplatin co-treated with Fluorouracil] results in decreased expression of ALB protein
CTD
PMID:20180123
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
Angptl2
angiopoietin-like 2
multiple interactions
ISO
ANGPTL2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 3:12,262,822...12,292,665
Ensembl chr 3:12,262,822...12,292,663
G
Arl6ip5
ADP-ribosylation factor like GTPase 6 interacting protein 5
multiple interactions
ISO
ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; ARL6IP5 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
CTD
PMID:22452940
NCBI chr 4:129,574,363...129,598,240
Ensembl chr 4:129,574,264...129,598,915
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
multiple interactions
ISO
ATP5PO mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr11:32,081,606...32,087,918
Ensembl chr11:32,081,574...32,088,002
G
Axin2
axin 2
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of AXIN2 mRNA
CTD
PMID:25187349
NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
G
Bglap
bone gamma-carboxyglutamate protein
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of BGLAP mRNA
CTD
PMID:25187349
NCBI chr 2:187,741,770...187,748,445
Ensembl chr 2:187,741,770...187,742,747
G
Boll
boule homolog, RNA binding protein
multiple interactions
ISO
BOLL mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 9:61,836,517...61,975,640
Ensembl chr 9:64,480,031...64,573,660 Ensembl chr 9:64,480,031...64,573,660
G
Casp3
caspase 3
multiple interactions
ISO
[10-hydroxycamptothecin co-treated with Fluorouracil co-treated with Leucovorin] results in increased activity of CASP3 protein
CTD
PMID:12934351
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Ccnd1
cyclin D1
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of CCND1 mRNA
CTD
PMID:25187349
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccne1
cyclin E1
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CCNE1 mRNA
CTD
PMID:15342418
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Cdc45
cell division cycle 45
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDC45 mRNA
CTD
PMID:15342418
NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
G
Cdc6
cell division cycle 6
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDC6 mRNA
CTD
PMID:15342418
NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDK1 mRNA
CTD
PMID:15342418
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
G
Cdk2
cyclin dependent kinase 2
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDK2 mRNA
CTD
PMID:15342418
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in increased expression of CDKN1A mRNA
CTD
PMID:15342418
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
G
Ctnnb1
catenin beta 1
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein
CTD
PMID:25187349
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
EXP
Leucovorin affects the reaction [Methotrexate results in decreased expression of CYP11A1 mRNA]; Leucovorin affects the reaction [Methotrexate results in decreased expression of CYP11A1 protein]
CTD
PMID:21213337
NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
G
Dhfr
dihydrofolate reductase
multiple interactions increases expression
ISO
Leucovorin inhibits the reaction [DHFR gene mutant form results in decreased abundance of Folic Acid] Leucovorin results in increased expression of DHFR protein
CTD
PMID:16712799 PMID:21310277
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions
ISO
[Leucovorin co-treated with Fluorouracil] results in decreased activity of DPYD protein
CTD
PMID:7503095
NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
G
Drd5
dopamine receptor D5
multiple interactions
ISO
DRD5 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr14:77,220,579...77,222,006
Ensembl chr14:77,220,579...77,222,006
G
Edn1
endothelin 1
increases expression
ISO
Leucovorin results in increased expression of EDN1 mRNA; Leucovorin results in increased expression of EDN1 protein
CTD
PMID:16925845
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
G
Eml2
EMAP like 2
multiple interactions
ISO
EML2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 1:80,087,684...80,118,784
Ensembl chr 1:80,087,684...80,119,012
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
multiple interactions
ISO
ERCC1 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
CTD
PMID:17401013
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
multiple interactions
ISO
ERCC2 gene SNP affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
CTD
PMID:17401013
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
G
F8
coagulation factor VIII
multiple interactions
ISO
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr18:367,862...399,242
Ensembl chr18:367,862...399,242
G
Fabp4
fatty acid binding protein 4
multiple interactions
EXP
Leucovorin inhibits the reaction [Methotrexate results in increased expression of FABP4 protein]
CTD
PMID:25187349
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Folr1
folate receptor alpha
multiple interactions
ISO
FOLR1 protein affects the reaction [Leucovorin results in increased phosphorylation of STAT3 protein]
CTD
PMID:25841994
NCBI chr 1:166,934,457...166,945,864
Ensembl chr 1:166,934,460...166,943,592
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
Leucovorin affects the reaction [Methotrexate results in increased expression of FSHB protein]
CTD
PMID:21213337
NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
EXP
Leucovorin inhibits the reaction [Methotrexate results in decreased activity of G6PD protein]
CTD
PMID:21213337
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
G
Hand2
heart and neural crest derivatives expressed 2
increases expression
ISO
Leucovorin results in increased expression of HAND2 mRNA; Leucovorin results in increased expression of HAND2 protein
CTD
PMID:16925845
NCBI chr16:36,371,489...36,373,551
Ensembl chr16:36,371,489...36,373,546
G
Hspb1
heat shock protein family B (small) member 1
multiple interactions
ISO
HSPB1 protein affects the susceptibility to [Cisplatin co-treated with Fluorouracil co-treated with Leucovorin]
CTD
PMID:19088045
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Leucovorin inhibits the reaction [Methotrexate results in increased expression of IL1B mRNA]
CTD
PMID:24444433
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
multiple interactions
ISO
Leucovorin inhibits the reaction [Methotrexate results in increased expression of IL6 mRNA]
CTD
PMID:24444433
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Il6st
interleukin 6 cytokine family signal transducer
multiple interactions
ISO
IL6ST protein affects the reaction [Leucovorin results in increased phosphorylation of STAT3 protein]
CTD
PMID:25841994
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
G
Lef1
lymphoid enhancer binding factor 1
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of LEF1 mRNA
CTD
PMID:25187349
NCBI chr 2:236,232,115...236,345,061
Ensembl chr 2:236,233,239...236,345,056
G
Lgals8
galectin 8
multiple interactions
ISO
LGALS8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr17:66,487,451...66,515,316
Ensembl chr17:66,487,457...66,511,870
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
Leucovorin affects the reaction [Methotrexate results in increased expression of LHB protein]
CTD
PMID:21213337
NCBI chr 1:101,409,992...101,413,725
Ensembl chr 1:101,410,019...101,413,724
G
LOC102548162
zinc finger protein 582-like
multiple interactions
ISO
ZNF582 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 1:71,206,073...71,228,209
G
Mat2a
methionine adenosyltransferase 2A
multiple interactions
ISO
Leucovorin inhibits the reaction [Methotrexate results in decreased expression of MAT2A mRNA]
CTD
PMID:22193356
NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
G
Mthfr
methylenetetrahydrofolate reductase
multiple interactions
ISO
MTHFR gene polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin]
CTD
PMID:18633250
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA; [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein
CTD
PMID:25187349
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Serpine2
serpin family E member 2
multiple interactions
ISO
SERPINE2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 9:85,560,852...85,629,410
Ensembl chr 9:85,560,863...85,626,094
G
Sfrp1
secreted frizzled-related protein 1
multiple interactions
EXP
Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 mRNA]; Leucovorin inhibits the reaction [Methotrexate results in increased expression of SFRP1 protein]
CTD
PMID:25187349
NCBI chr16:73,372,007...73,410,777
Ensembl chr16:73,372,007...73,410,777
G
Slc19a1
solute carrier family 19 member 1
multiple interactions
ISO
Leucovorin inhibits the reaction [SLC19A1 protein results in increased transport of Methotrexate]
CTD
PMID:21879757
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
EXP ISO
Leucovorin inhibits the reaction [Methotrexate results in decreased expression of SLC22A6 protein] SLC22A6 protein results in increased uptake of Leucovorin
CTD
PMID:16098483 PMID:16925582
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
EXP ISO
Leucovorin inhibits the reaction [Methotrexate results in decreased expression of SLC22A8 protein] SLC22A8 protein results in increased uptake of Leucovorin
CTD
PMID:16098483 PMID:16925582
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Slc46a1
solute carrier family 46 member 1
decreases activity multiple interactions
ISO
Leucovorin results in decreased activity of SLC46A1 protein Leucovorin inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]
CTD
PMID:17475902
NCBI chr10:65,728,508...65,741,708
Ensembl chr10:65,733,991...65,740,828
G
Sp7
Sp7 transcription factor
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of SP7 mRNA
CTD
PMID:25187349
NCBI chr 7:143,957,316...143,967,488
Ensembl chr 7:143,958,858...143,967,484
G
Star
steroidogenic acute regulatory protein
multiple interactions
EXP
Leucovorin affects the reaction [Methotrexate results in decreased expression of STAR mRNA]; Leucovorin affects the reaction [Methotrexate results in decreased expression of STAR protein]
CTD
PMID:21213337
NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
FOLR1 protein affects the reaction [Leucovorin results in increased phosphorylation of STAT3 protein]; IL6ST protein affects the reaction [Leucovorin results in increased phosphorylation of STAT3 protein]; Leucovorin results in increased activity of and results in increased phosphorylation of STAT3 protein
CTD
PMID:25841994
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Tymp
thymidine phosphorylase
multiple interactions
ISO
TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin]
CTD
PMID:17454858
NCBI chr 7:130,342,481...130,347,845
Ensembl chr 7:130,342,483...130,347,587
G
Tyms
thymidylate synthetase
multiple interactions
ISO
[arsenic trioxide co-treated with Fluorouracil co-treated with Leucovorin] results in decreased expression of TYMS mRNA; TYMS gene polymorphism results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with Cisplatin co-treated with Paclitaxel]; TYMS mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin]; TYMS promoter polymorphism results in increased susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin co-treated with docetaxel]; TYMS protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin] Leucovorin promotes the reaction [Fluorouracil results in decreased expression of TYMS]
CTD
PMID:9050858 PMID:16424979 PMID:17454858 PMID:18676755 PMID:19074750 PMID:20501625
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
Wnt10b
Wnt family member 10B
multiple interactions
EXP
[Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA
CTD
PMID:25187349
NCBI chr 7:140,448,284...140,466,159
Ensembl chr 7:140,448,465...140,454,268
G
Xrcc1
X-ray repair cross complementing 1
multiple interactions
ISO
XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with Cisplatin]; XRCC1 protein affects the susceptibility to [Fluorouracil co-treated with Leucovorin co-treated with oxaliplatin]
CTD
PMID:22452940
NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
G
Zfp637
zinc finger protein 637
multiple interactions
ISO
ZNF32 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr 4:149,857,127...149,882,828
Ensembl chr 4:149,877,889...149,882,824
G
Zrsr2
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2
multiple interactions
ISO
ZRSR2 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan]
CTD
PMID:17327601
NCBI chr X:32,304,707...32,327,419
Ensembl chr X:32,304,757...32,328,364
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
decreases abundance
ISO
ALDH1L1 protein results in decreased abundance of 5-methyltetrahydrofolate
CTD
PMID:16627483
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
G
Folr1
folate receptor alpha
increases uptake
ISO
FOLR1 protein results in increased uptake of 5-methyltetrahydrofolate
CTD
PMID:17473184
NCBI chr 1:166,934,457...166,945,864
Ensembl chr 1:166,934,460...166,943,592
G
Gnmt
glycine N-methyltransferase
affects binding
EXP
GNMT protein binds to 5-methyltetrahydrofolate
CTD
PMID:17158459
NCBI chr 9:16,565,274...16,568,626
Ensembl chr 9:16,565,225...16,568,627
G
Mthfr
methylenetetrahydrofolate reductase
increases chemical synthesis
ISO
MTHFR protein results in increased chemical synthesis of 5-methyltetrahydrofolate
CTD
PMID:7647779 PMID:9719624
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
affects binding
ISO
5-methyltetrahydrofolate binds to MTR protein
CTD
PMID:17477549
NCBI chr17:66,210,444...66,295,014
Ensembl chr17:66,210,461...66,295,014
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
affects abundance
ISO
MTRR protein affects the abundance of 5-methyltetrahydrofolate
CTD
PMID:17369066
NCBI chr 1:37,743,089...37,774,485
Ensembl chr 1:37,743,147...37,774,015
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
[Docosahexaenoic Acids co-treated with 5-methyltetrahydrofolate] results in increased expression of PCNA protein
CTD
PMID:16870008
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
Slc19a1
solute carrier family 19 member 1
multiple interactions decreases activity
ISO EXP
[5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid 5-methyltetrahydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate]
CTD
PMID:14612385 PMID:17034785
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
G
Slc46a1
solute carrier family 46 member 1
multiple interactions decreases activity
ISO
5-methyltetrahydrofolate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] 5-methyltetrahydrofolate results in decreased activity of SLC46A1 protein
CTD
PMID:17475902
NCBI chr10:65,728,508...65,741,708
Ensembl chr10:65,733,991...65,740,828
G
Stk11
serine/threonine kinase 11
multiple interactions
ISO
5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]; dorsomorphin inhibits the reaction [5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [5-methyltetrahydrofolate inhibits the reaction [Palmitic Acid results in decreased phosphorylation of STK11 protein]]
CTD
PMID:26400185
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all